HATCH Score for Predicting Mortality in COVID-19 Patients

Gökhan  Alıcı; Ömer  Genç; Hazar  Harbalıoğlu; Ahmed Muhammad  Başhir; Samir  Allahverdiyev; Abdullah  Yıldırım; Alaa  Quisi; Örsan Deniz  Urgun; İbrahim Halil  Kurt

doi:10.18502/ijph.v51i12.11462

Gökhan Alıcı Department of Cardiology, Adana City Training and Research Hospital, University of Health Sciences, Adana, Turkey
Ömer Genç Department of Cardiology, Cam and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey
Hazar Harbalıoğlu Department of Cardiology, Duzce Atatürk State Hospital, Duzce, Turkey
Ahmed Muhammad Başhir Department of Internal Medicine, Somalia-Turkey Training and Research Hospital, Mogadishu, Somalia
Samir Allahverdiyev Department of Cardiology, Istanbul Aydın University VM Medical Park Florya Hospital, Istanbul, Turkey
Abdullah Yıldırım Department of Cardiology, Adana City Training and Research Hospital, University of Health Sciences, Adana, Turkey
Alaa Quisi Department of Cardiology, Medline Hospital Adana, Adana, Turkey
Örsan Deniz Urgun Department of Cardiology, Kozan State Hospital, Adana, Turkey
İbrahim Halil Kurt Department of Cardiology, Adana City Training and Research Hospital, University of Health Sciences, Adana, Turkey

DOI: https://doi.org/10.18502/ijph.v51i12.11462

Keywords: SARS-CoV-2; Score; Mortality

Abstract

Background: We aimed to evaluate the relationship between HATCH score [hypertension, age >75 yr, previous transient ischemic attack (TIA) or stroke (doubled), chronic obstructive pulmonary disease, heart failure (doubled)] and in-hospital mortality in COVID-19 patients.

Methods: Overall, 572 COVID-19 patients hospitalized between Mar 15 and Apr 15, 2020, were included in this multicenter retrospective study, in Turkey. The HATCH score of each patient was calculated. Mortality results were followed for 50 days. The patients were divided into 2 groups developing mortality (n=267) and non-mortality (n=305). Clinical outcomes were defined as in-hospital mortality improvement status.

Results: HATCH scores in non-survivors of COVID-19 were significantly higher than in survivors (P<0.001). In logistic regression analysis, HATCH score (OR: 1.253, 95% CI: 1.003–1.565; P=0.047), platelet count (OR: 0.995, 95% CI: 0.993-0.998; P<0.001), C-reactive protein level (OR: 1.010, 95% CI: 1.007-1.013, P<0.001) and estimated glomerular filtration ratio (eGFR) level (OR: 0.963, 95% CI: 0.953-0.973; P<0.001) were independent predictors of in-hospital mortality in COVID-19 patients.

Conclusion: The HATCH score is useful in predicting in-hospital mortality in patients hospitalized with COVID-19.